Perritt Capital Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-200,000
Closed -$426K 222
2018
Q4
$426K Hold
200,000
0.16% 150
2018
Q3
$914K Hold
200,000
0.27% 103
2018
Q2
$980K Hold
200,000
0.28% 103
2018
Q1
$994K Hold
200,000
0.29% 102
2017
Q4
$976K Sell
200,000
-218,663
-52% -$1.02M 0.27% 110
2017
Q3
$1.82M Hold
418,663
0.48% 72
2017
Q2
$1.86M Hold
418,663
0.49% 73
2017
Q1
$1.74M Buy
418,663
+292,494
+232% +$1.25M 0.44% 84
2016
Q4
$521K Buy
+126,169
New +$615K 0.13% 154

Other funds holding ASPN

Perritt Capital Management's ASPN Position: Q1 2019 in Review

Perritt Capital Management sold out of Aspen Aerogels (ASPN) in Q1 2019, closing a stake of 200,000 shares — an estimated $426K sold.

Perritt Capital Management first reported a position in ASPN in Q4 2016 and held it in 9 quarters. The position peaked at $1.86M in Q2 2017. 34 funds tracked by Wall St. Rank hold ASPN as of Q1 2019.

  • Perritt Capital Management reported no remaining Aspen Aerogels position as of Q1 2019 after selling out during the quarter.
  • Perritt Capital Management sold 200,000 Aspen Aerogels shares in Q1 2019, an estimated $426K.
  • Perritt Capital Management first reported a position in Aspen Aerogels in Q4 2016 and held it in 9 quarters.
  • Perritt Capital Management's Aspen Aerogels position peaked at $1.86M in Q2 2017.
  • 34 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2019.

Based on Perritt Capital Management's 13F filing for Q1 2019, filed 13 May 2019.